{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:34:14Z","timestamp":1790786054252,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd002243.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000}}],"reference-count":186,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002243.pub4","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T07:04:44Z","timestamp":1575615884000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Corticosteroids for treating sepsis in children and adults"],"prefix":"10.1002","volume":"2019","author":[{"given":"Djillali","family":"Annane","sequence":"first","affiliation":[{"name":"Center for Neuromuscular Diseases; Raymond Poincar\u00e9 Hospital (AP-HP); Department of Critical Care, Hyperbaric Medicine and Home Respiratory Unit; Faculty of Health Sciences Simone Veil, University of Versailles SQY- University of Paris Saclay 104 Boulevard Raymond Poincar\u00e9 Garches France 92380"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bellissant","sequence":"additional","affiliation":[{"name":"H\u00f4pital Pontchaillou; Centre d'Investigation Clinique INSERM 0203; Rennes France 35033"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre Edouard","family":"Bollaert","sequence":"additional","affiliation":[{"name":"H\u00f4pital Central; Intensive Care Unit; Nancy France 54000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Briegel","sequence":"additional","affiliation":[{"name":"Klinikum der Universit\u00e4t; Klinik fur An\u00e4sthesiologie; M\u00fcnchen Germany 81377"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Keh","sequence":"additional","affiliation":[{"name":"Charit\u00e9-Campus Virchow Clinic, Charit\u00e9 Universit\u00e4tsmedizin Berlin; University Clinic of Anesthesiology and Intensive Care Medicine CCM\/CVK; Augustenburger Platz 1 Berlin Germany 13353"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhak","family":"Kupfer","sequence":"additional","affiliation":[{"name":"Maimonides Medical Center; Division of Pulmonary and Critical Care Medicine; 4802 Tenth Avenue Brooklyn New York USA 11219"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Pirracchio","sequence":"additional","affiliation":[{"name":"Zuckerberg San Francisco General Hospital and Trauma Center, University of California; Department of Anesthesia and Perioperative Medicine; San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Rochwerg","sequence":"additional","affiliation":[{"name":"McMaster University; Division of Critical Care, Department of Medicine; Box 211, Juravinski Hospital 711 Concession St Hamilton Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,12,6]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD002243.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/CCM.0b013e31816f48f2","article-title":"Hydrocortisone effects on cardiovascular variability in septic shock: a spectral analysis approach","volume":"36","author":"Aboab","year":"2008","journal-title":"Critical Care Medicine"},{"issue":"7","key":"10.1002\/14651858.CD002243.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD002243.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.2010.2","article-title":"Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial","volume":"303","author":"Annane","year":"2010","journal-title":"JAMA"},{"issue":"9","key":"10.1002\/14651858.CD002243.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"18","key":"10.1002\/14651858.CD002243.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1503\/cmaj.090707","article-title":"Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial","volume":"182","author":"Arabi","year":"2010","journal-title":"Canadian Medical Association Journal"},{"issue":"9977","key":"10.1002\/14651858.CD002243.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","article-title":"Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"385","author":"Blum","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD002243.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00003246-199804000-00010","article-title":"Reversal of late septic shock with supraphysiologic doses of hydrocortisone","volume":"26","author":"Bollaert","year":"1998","journal-title":"Critical Care Medicine"},{"issue":"11","key":"10.1002\/14651858.CD002243.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJM198709103171101","article-title":"A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock","volume":"317","author":"Bone","year":"1987","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD002243.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00003246-199904000-00025","article-title":"Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study","volume":"27","author":"Briegel","year":"1999","journal-title":"Critical Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002243.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"A33","DOI":"10.1097\/00003246-199901001-00022","article-title":"Hydrocortisone reverses refractory septic shock","volume":"27","author":"Chawla","year":"1999","journal-title":"Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD002243.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1590\/S1516-31802007000400009","article-title":"Early dexamethasone treatment for septic shock patients: a prospective randomized clinical trial","volume":"125","author":"Cicarelli","year":"2007","journal-title":"Sao Paulo Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD002243.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","article-title":"Hydrocortisone infusion for severe community acquired pneumonia: a preliminary randomized study","volume":"171","author":"Confalonieri","year":"2005","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"6","key":"10.1002\/14651858.CD002243.pub4-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/jama.1963.63700060029012","article-title":"The effectiveness of hydrocortisone in the management of severe infections","volume":"183","author":"Cooperative Study Group","year":"1963","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.15171\/JEPT.2017.25","article-title":"The effect of physiologic dose of intravenous hydrocortisone in patients with refractory septic shock: a randomized control trial","volume":"4","author":"Talebi Doluee","year":"2018","journal-title":"Journal of Emergency Practice and Trauma"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0015|cit15","first-page":"91","article-title":"Effects of low dose hydrocortisone in ICU patients with severe community acquired pneumonia","volume":"55","author":"El-Ghamraway","year":"2006","journal-title":"Egyptian Journal of Chest"},{"issue":"2","key":"10.1002\/14651858.CD002243.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/INF.0000000000001380","article-title":"Evaluation of early corticosteroid therapy in management of paediatric septic shock in paediatric intensive care patients: a randomized clinical study","volume":"36","author":"El-Nawawy","year":"2017","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"2","key":"10.1002\/14651858.CD002243.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"R96","DOI":"10.1186\/cc10103","article-title":"Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial","volume":"15","author":"Fern\u00e1ndez-Serrano","year":"2011","journal-title":"Critical Care"},{"issue":"6","key":"10.1002\/14651858.CD002243.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/CCM.0000000000000212","article-title":"The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial","volume":"42","author":"Gordon","year":"2014","journal-title":"Critical Care Medicine"},{"issue":"5","key":"10.1002\/14651858.CD002243.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"10.1002\/14651858.CD002243.pub4-BIB0020|cit20","first-page":"529","article-title":"The effect of low-dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock","volume":"21","author":"Hu","year":"2009","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"issue":"3","key":"10.1002\/14651858.CD002243.pub4-BIB0021|cit21","first-page":"184","article-title":"Effect of Sini decoction on function of hypothalamic-pituitary-adrenal axis in patients with sepsis","volume":"26","author":"Huang","year":"2014","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"issue":"12 suppl","key":"10.1002\/14651858.CD002243.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"A101","DOI":"10.1097\/00003246-200612002-00350","article-title":"Effect of low doses of hydrocortisone in patient with septic shock and relative adrenal insufficiency: 3 days versus 7 days treatment","volume":"34","author":"Huh","year":"2006","journal-title":"Critical Care Medicine"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/SHK.0000000000000665","article-title":"Effects of increasing hydrocortisone to 300\u200amg per day in the treatment of septic shock: a pilot study","volume":"46","author":"Hyvernat","year":"2016","journal-title":"Shock"},{"issue":"4","key":"10.1002\/14651858.CD002243.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1164\/rccm.200205-446OC","article-title":"Immunologic and hemodynamic effects of \"low-dose\" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study","volume":"167","author":"Keh","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"17","key":"10.1002\/14651858.CD002243.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.2016.14799","article-title":"Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial","volume":"316","author":"Keh","year":"2016","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0026|cit26","article-title":"Effect of steroids in septic shock patients without relative adrenal insufficiency","volume":"116","author":"Kurugundla","year":"2008","journal-title":"American Thoracic Society"},{"issue":"9","key":"10.1002\/14651858.CD002243.pub4-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3760\/cma.j.issn.2095-4352.2016.09.003","article-title":"Value of glucocorticoid steroids in the treatment of patients with severe community acquired pneumonia complicated with septic shock","volume":"28","author":"Li","year":"2016","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"issue":"8","key":"10.1002\/14651858.CD002243.pub4-BIB0028|cit28","first-page":"599","article-title":"The effect of stress dose glucocorticoid on patients with acute respiratory distress syndrome combined with critical illness-related corticosteroid insufficiency","volume":"51","author":"Liu","year":"2012","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"1","key":"10.1002\/14651858.CD002243.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1186\/cc5696","article-title":"Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial","volume":"11","author":"Loisa","year":"2007","journal-title":"Critical Care"},{"issue":"1","key":"10.1002\/14651858.CD002243.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1164\/ajrccm\/138.1.62","article-title":"Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock","volume":"138","author":"Luce","year":"1988","journal-title":"American Review of Respiratory Diseases"},{"issue":"12","key":"10.1002\/14651858.CD002243.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ajem.2017.06.004","article-title":"Early initiation of low-dose hydrocortisone treatment for septic shock in adults: a randomized clinical trial","volume":"35","author":"Lv","year":"2017","journal-title":"American Journal of Emergency Medicine"},{"issue":"5840","key":"10.1002\/14651858.CD002243.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/bmj.4.5840.569","article-title":"Ampicillin dosage and use of prednisolone in treatment of pneumonia: co-operative controlled trial","volume":"4","author":"McHardy","year":"1972","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD002243.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1378\/chest.06-2100","article-title":"Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial","volume":"131","author":"Meduri","year":"2007","journal-title":"Chest"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0012-3692(16)48001-3","article-title":"Randomized clinical trial (RCT) evaluating the effects of low-dose prolonged hydrocortisone infusion on resolution of MODS in severe sepsis","volume":"136","author":"Meduri","year":"2009","journal-title":"Chest"},{"issue":"9782","key":"10.1002\/14651858.CD002243.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(11)60607-7","article-title":"Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Meijvis","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD002243.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/PCC.0000000000001121","article-title":"A randomized controlled trial of corticosteroids in paediatric septic shock: a pilot feasibility study","volume":"18","author":"Menon","year":"2017","journal-title":"Pediatric Critical Care Medicine"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1186\/cc13429","article-title":"Continuous administration of corticosteroids in septic shock can reduce risk of hypernatraemia","volume":"18","author":"Mirea","year":"2014","journal-title":"Critical Care"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejcdt.2013.03.009","article-title":"Adjuvant role of corticosteroids in the treatment of community acquired pneumonia","volume":"62","author":"Nafae","year":"2013","journal-title":"Egyptian Journal of Chest Diseases and Tuberculosis"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ppul.22574","article-title":"Efficacy of methylprednisolone in children with severe community acquired pneumonia","volume":"48","author":"Nagy","year":"2013","journal-title":"Pediatric Pulmonology"},{"issue":"3","key":"10.1002\/14651858.CD002243.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/SHK.0000000000001061","article-title":"Clinical outcomes of minimized hydrocortisone dosage of 100mg\/day on lower occurrence of hyperglycaemia in septic shock","volume":"50","author":"Ngaosuwan","year":"2018","journal-title":"Shock"},{"issue":"11","key":"10.1002\/14651858.CD002243.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1097\/01.CCM.0000186370.78639.23","article-title":"Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock","volume":"33","author":"Oppert","year":"2005","journal-title":"Critical Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002243.pub4-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"167-72","DOI":"10.1016\/j.ejcdt.2013.02.013","article-title":"Effects of methyl prednisolone in early ARDS","volume":"62","author":"Rezk","year":"2013","journal-title":"Egyptian Journal of Chest Diseases and Tuberculosis"},{"issue":"9","key":"10.1002\/14651858.CD002243.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1097\/01.CCM.0000233872.04706.BB","article-title":"Low-dose hydrocortisone during severe sepsis: effects on microalbuminemia","volume":"34","author":"Rinaldi","year":"2006","journal-title":"Critical Care Medicine"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4236\/pp.2011.22009","article-title":"Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings","volume":"2","author":"Sabry","year":"2011","journal-title":"Pharmacology and Pharmacy"},{"issue":"3","key":"10.1002\/14651858.CD002243.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00000658-197609000-00011","article-title":"Steroids in the treatment of clinical septic shock","volume":"184","author":"Schumer","year":"1976","journal-title":"Annals of Surgery"},{"issue":"7","key":"10.1002\/14651858.CD002243.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00006454-199607000-00004","article-title":"Randomized, placebo-controlled, double blinded trial of dexamethasone in African children with sepsis","volume":"15","author":"Slusher","year":"1996","journal-title":"Pediatric Infectious Diseases Journal"},{"issue":"9","key":"10.1002\/14651858.CD002243.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.200905-0808OC","article-title":"Efficacy of corticosteroids in community-acquired pneumonia - a randomized double blinded clinical trial","volume":"181","author":"Snijders","year":"2010","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"18","key":"10.1002\/14651858.CD002243.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM198411013111801","article-title":"The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study","volume":"311","author":"Sprung","year":"1984","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD002243.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0050|cit50","first-page":"1171","article-title":"Clinical efficacy in the treatment of severe community acquired pneumonia and its impact on CRP","volume":"18","author":"Sui","year":"2013","journal-title":"Chinese Journal of Integrative Medicine"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jpeds.2017.02.043","article-title":"Dexamethasone for parapneumonic pleural effusion: a randomized, double-blind, clinical trial","volume":"185","author":"Tagaro","year":"2017","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0052|cit52","unstructured":"Tandan SM Guleria R Gupta N Low dose steroids and adrenocortical insufficiency in septic shock: a double-blind randomised controlled trial from India Proceedings of the American Thoracic Society Meeting 2005 A24"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/SHK.0000000000001316.","article-title":"Comparison between continuous and intermittent administration of hydrocortisone during septic shock: a randomized controlled clinical trial","volume":"52","author":"Tilouche","year":"2019","journal-title":"Shock"},{"issue":"1","key":"10.1002\/14651858.CD002243.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s13054-016-1511-2","article-title":"Hydrocortisone treatment in early sepsis associated acute respiratory distress syndrome: results of a randomized controlled trial","volume":"20","author":"Tongyoo","year":"2016","journal-title":"Critical Care"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0055|cit55","doi-asserted-by":"crossref","unstructured":"Torres A Sibila O Ferrer M Polverino E Menendez R Mensa J Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial JAMA 2015 677 86","DOI":"10.1001\/jama.2015.88"},{"issue":"1","key":"10.1002\/14651858.CD002243.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/PCC.0b013e3181936ab3","article-title":"Low-dose hydrocortisone in paediatric septic shock: an exploratory study in a third world setting","volume":"10","author":"Valoor","year":"2009","journal-title":"Pediatric Critical Care Medicine"},{"issue":"11","key":"10.1002\/14651858.CD002243.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM198709103171102","article-title":"Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis","volume":"317","author":"Veterans Administration Systemic Sepsis Cooperative Study Group","year":"1987","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"797-808","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"18","key":"10.1002\/14651858.CD002243.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1056\/NEJMc1803563","article-title":"Long-term outcomes of the ADRENAL trial","volume":"378","author":"Venkatesh","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD002243.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/cc1498","article-title":"Physiological-dose steroid therapy in sepsis","volume":"6","author":"Yildiz","year":"2002","journal-title":"Critical Care"},{"issue":"11","key":"10.1002\/14651858.CD002243.pub4-BIB0061|cit61","first-page":"1410","article-title":"The effects of moderate-dose steroid therapy in sepsis: a placebo-controlled, randomized study","volume":"16","author":"Yildiz","year":"2011","journal-title":"Journal of Research in Medical Sciences"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3969\/j.issn.1674-4659.2015.01.0057","article-title":"Application value of glucocorticoid for comprehensive treatment of acute respiratory distress syndrome induced by serious community acquired pneumonia","volume":"22","author":"Zhou","year":"2015","journal-title":"Clinical Medicine and Engineering"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S2213-2600(14)70144-4","article-title":"Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial","volume":"2","author":"Asehnoune","year":"2014","journal-title":"The Lancet. Respiratory Medicine"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM198712173172504","article-title":"High-dose corticosteroids in patients with the adult respiratory distress syndrome","volume":"317","author":"Bernard","year":"1987","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD002243.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1590\/S1516-31802006000200008","article-title":"Effects of single dose of dexamethasone on patients with systemic inflammatory response","volume":"124","author":"Cicarelli","year":"2006","journal-title":"Sao Paulo Medical Journal"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI102441","article-title":"Effect of cortisone on acute streptococcal infections and post-streptococcal complications","volume":"30","author":"Hahn","year":"1951","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/tropej\/fmu022","article-title":"Early treatment with corticosteroids in patients with Mycoplasma pneumoniae pneumonia: a randomized clinical trial","volume":"64","author":"Huang","year":"2014","journal-title":"Journal of Tropical Pediatrics"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"436.e7","DOI":"10.1016\/j.jcrc.2014.09.016","article-title":"Low dose of glucocorticoid decreases the incidence of complications in severely burned patients by attenuating systemic inflammation","volume":"436","author":"Huang","year":"2015","journal-title":"J Crit Care"},{"issue":"23","key":"10.1002\/14651858.CD002243.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/0024-3205(84)90523-X","article-title":"Naloxone and methylprednisolone sodium succinate enhance sympathomedullary discharge in patients with septic shock","volume":"35","author":"Hughes","year":"1984","journal-title":"Life Sciences"},{"issue":"2","key":"10.1002\/14651858.CD002243.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00134-007-0868-8","article-title":"Stress doses of hydrocortisone in septic shock: beneficial effects on opsonization-dependent neutrophil functions","volume":"34","author":"Kaufmann","year":"2008","journal-title":"Intensive Care Medicine"},{"issue":"22","key":"10.1002\/14651858.CD002243.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJM197106032842206","article-title":"Effectiveness of betamethasone in management of severe infections. A double-blind study","volume":"284","author":"Klastersky","year":"1971","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0072|cit72","first-page":"779","article-title":"Effectiveness of methylprednisolone in treatment of children with refractory Mycoplasma pneumoniae pneumonia and its relationship with bronchoalveolar lavage cytokine levels","volume":"53","author":"Lan","year":"2015","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"5","key":"10.1002\/14651858.CD002243.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/archsurg.1984.01390170037008","article-title":"The cardiopulmonary response to massive doses of steroids in patients with septic shock","volume":"119","author":"Lucas","year":"1984","journal-title":"Archives of Surgery"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ppul.22752","article-title":"Effects of prednisolone on refractory Mycoplasma pneumoniae pneumonia in children","volume":"49","author":"Luo","year":"2014","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1378\/chest.104.2.389","article-title":"Hydrocortisone and tumour necrosis factor in severe community-acquired pneumonia. A randomized controlled study","volume":"104","author":"Marik","year":"1993","journal-title":"Chest"},{"issue":"8322","key":"10.1002\/14651858.CD002243.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0140-6736(83)91489-7","article-title":"Cortisol replacement in severely stressed patients","volume":"1","author":"McKee","year":"1983","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD002243.pub4-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.280.2.159","article-title":"Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial","volume":"280","author":"Meduri","year":"1998","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD002243.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00408-007-9020-3","article-title":"Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization","volume":"185","author":"Mikami","year":"2007","journal-title":"Lung"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/20469047.2016.1260891","article-title":"Early use of corticosteroids in infants with a clinical diagnosis of Pneumocystis jiroveci pneumonia in Malawi: a double-blind, randomised clinical trial","volume":"37","author":"Newberry","year":"2017","journal-title":"Paediatr Int Child Health."},{"key":"10.1002\/14651858.CD002243.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1007\/s00134-018-5427-y","article-title":"ACTH and cortisol responses to CRH in acute, subacute, and prolonged critical illness: a randomized, double-blind, placebo-controlled, crossover cohort study","volume":"44","author":"Peeters","year":"2018","journal-title":"Intensive Care Medicine"},{"issue":"6","key":"10.1002\/14651858.CD002243.pub4-BIB0081|cit81","first-page":"742","article-title":"Large doses of steroids in septicaemic shock","volume":"42","author":"Rogers","year":"1970","journal-title":"British Journal of Urology"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/jama.2011.360","article-title":"Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study","volume":"305","author":"Roquilly","year":"2011","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cyto.2015.10.007","article-title":"Regulation of inflammatory biomarkers by intravenous methylprednisolone in pediatric ARDS patients: results from a double-blind, placebo-controlled randomized pilot trial","volume":"77","author":"Schwingshackl","year":"2016","journal-title":"Cytokine"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa051693","article-title":"Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome","volume":"354","author":"Steinberg","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD002243.pub4-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/cid\/cis655","article-title":"Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial","volume":"55","author":"Tam","year":"2012","journal-title":"Clinical Infectious Disease"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0086|cit86","first-page":"258A","article-title":"Inefficacy of glucocorticoids in shock (double-blind study)","volume":"24","author":"Thompson","year":"1976","journal-title":"Clinical Research"},{"issue":"5","key":"10.1002\/14651858.CD002243.pub4-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/thorax.58.5.383","article-title":"Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus","volume":"58","author":"Woensel","year":"2003","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13054-015-0740-0","article-title":"Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial","volume":"19","author":"Venet","year":"2015","journal-title":"Critical Care"},{"issue":"3","key":"10.1002\/14651858.CD002243.pub4-BIB0089|cit89","first-page":"197","article-title":"The effect of hydrocortisone upon the course of pneumococcal pneumonia treated with penicillin","volume":"98","author":"Wagner","year":"1955","journal-title":"Bulletin of Johns Hopkins Hospital"},{"issue":"5","key":"10.1002\/14651858.CD002243.pub4-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/archsurg.1985.01390290018003","article-title":"Early steroid therapy for respiratory failure","volume":"120","author":"Weigelt","year":"1985","journal-title":"Archives of Surgery"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0091|cit91","unstructured":"NCT02517489 Community-acquired pneumonia: evaluation of corticosteroids (CAPE COD) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02517489."},{"key":"10.1002\/14651858.CD002243.pub4-BIB0092|cit92","unstructured":"NCT02602210 Supplemental corticosteroids in cirrhotic hypotensive patients with suspicion of sepsis (SCOTCH) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02602210."},{"key":"10.1002\/14651858.CD002243.pub4-BIB0093|cit93","unstructured":"NCT03258684 Hydrocortisone, vitamin C, and thiamine for the treatment of sepsis and septic shock (HYVCTTSSS) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03258684."},{"key":"10.1002\/14651858.CD002243.pub4-BIB0094|cit94","unstructured":"NCT03333278 The vitamin C, hydrocortisone and thiamine in patients with septic shock trial (VITAMINS) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03333278."},{"key":"10.1002\/14651858.CD002243.pub4-BIB0095|cit95","unstructured":"NCT03335124 The effect of vitamin C, thiamine and hydrocortisone on clinical course and outcome in patients with severe sepsis and septic shock https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03335124."},{"key":"10.1002\/14651858.CD002243.pub4-BIB0096|cit96","unstructured":"NCT03389555 Ascorbic acid, corticosteroids, and thiamine in sepsis (ACTS) trial https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03389555."},{"key":"10.1002\/14651858.CD002243.pub4-BIB0097|cit97","unstructured":"NCT03422159 Metabolic resuscitation using ascorbic acid, thiamine, and glucocorticoids in sepsis (ORANGES) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03422159."},{"key":"10.1002\/14651858.CD002243.pub4-BIB0098|cit98","unstructured":"NCT03509350 Vitamin C, thiamine, and steroids in sepsis (VICTAS) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03509350."},{"key":"10.1002\/14651858.CD002243.pub4-BIB0099|cit99","unstructured":"NCT03592693 Vitamin C, hydrocortisone and thiamine for septic shock (CORVICTES) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03592693."},{"issue":"6","key":"10.1002\/14651858.CD002243.pub4-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00003246-199206000-00025","article-title":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"20","author":"ACCP\/SCCM Consensus Conference","year":"1992","journal-title":"Critical Care Medicine"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/1060028018812940","article-title":"Recent updates in the pharmacological management of sepsis and septic shock: a systematic review focused on fluid resuscitation, vasopressors, and corticosteroids","volume":"53","author":"Allen","year":"2018","journal-title":"Annals of Pharmacotherapy"},{"issue":"21","key":"10.1002\/14651858.CD002243.pub4-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD002243.pub4-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1001\/jama.283.8.1038","article-title":"A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin","volume":"283","author":"Annane","year":"2000","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD002243.pub4-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1164\/rccm.2201087","article-title":"Current epidemiology of septic shock: the CUB-R\u00e9a Network","volume":"168","author":"Annane","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"9453","key":"10.1002\/14651858.CD002243.pub4-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(04)17667-8","article-title":"Septic shock","volume":"365","author":"Annane","year":"2005","journal-title":"Lancet"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD002243.pub4-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/CCM.0b013e318192078b","article-title":"Improving clinical trials in the critically ill: unique challenge: sepsis","volume":"37","author":"Annane","year":"2009","journal-title":"Critical Care Medicine"},{"issue":"12","key":"10.1002\/14651858.CD002243.pub4-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00134-017-4914-x","article-title":"Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM)","volume":"43","author":"Annane","year":"2017","journal-title":"Intensive Care Medicine"},{"issue":"12","key":"10.1002\/14651858.CD002243.pub4-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00134-017-4919-5","article-title":"Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017","volume":"43","author":"Annane","year":"2017","journal-title":"Intensive Care Medicine"},{"issue":"3","key":"10.1002\/14651858.CD002243.pub4-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1182\/blood-2009-10-247106","article-title":"Glucocorticoids promote survival of anti-inflammatory macrophages via stimulation of adenosine receptor A3","volume":"116","author":"Barczyk","year":"2010","journal-title":"Blood"},{"issue":"Suppl 6 Pt 2","key":"10.1002\/14651858.CD002243.pub4-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1164\/ajrccm\/152.6_Pt_2.S125","article-title":"Glucocorticoid resistance in asthma","volume":"152","author":"Barnes","year":"1995","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"16","key":"10.1002\/14651858.CD002243.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1214969","article-title":"Reduced cortisol metabolism during critical illness","volume":"388","author":"Boonen","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD002243.pub4-BIB0112|cit112","first-page":"782","article-title":"Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The Phospholipase A2 Study Group","volume":"72","author":"Briegel","year":"1994","journal-title":"Clinical Investigation"},{"issue":"4","key":"10.1002\/14651858.CD002243.pub4-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jcrc.2011.12.011","article-title":"US practitioner opinions and prescribing practices regarding corticosteroid therapy for severe sepsis and septic shock","volume":"27","author":"Bruno","year":"2012","journal-title":"Journal of Critical Care"},{"issue":"1","key":"10.1002\/14651858.CD002243.pub4-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"364-75","DOI":"10.1172\/JCI31539","article-title":"SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance","volume":"118","author":"Cai","year":"2008","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"10.1002\/14651858.CD002243.pub4-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nature Reviews. Immunology"},{"issue":"20","key":"10.1002\/14651858.CD002243.pub4-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM199505183322008","article-title":"The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation","volume":"322","author":"Chrousos","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD002243.pub4-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMra020529","article-title":"Corticosteroid insufficiency in acutely ill patients","volume":"348","author":"Cooper","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD002243.pub4-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/00003246-199508000-00019","article-title":"Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature","volume":"23","author":"Cronin","year":"1995","journal-title":"Critical Care Medicine"},{"issue":"3","key":"10.1002\/14651858.CD002243.pub4-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.4049\/jimmunol.178.3.1845","article-title":"Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia","volume":"178","author":"Kruif","year":"2007","journal-title":"Journal of Immunology"},{"issue":"15","key":"10.1002\/14651858.CD002243.pub4-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/jama.285.15.2000","article-title":"Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials","volume":"285","author":"Devereaux","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD002243.pub4-BIB0121|cit121","first-page":"91-6","article-title":"Dexamethasone improves vascular hyporeactivity induced by LPS in vivo by modulating ATP-sensitive potassium channel activity","volume":"140","author":"Villa Bianca","year":"2003","journal-title":"British Journal of Pharmacology"},{"issue":"11","key":"10.1002\/14651858.CD002243.pub4-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"2304-10","DOI":"10.1097\/01.CCM.0000145996.57901.D7","article-title":"Inhibition of glucocorticoid receptor binding by nitric oxide in endotoxemic rats","volume":"32","author":"Duma","year":"2004","journal-title":"Critical Care Medicine"},{"issue":"7109","key":"10.1002\/14651858.CD002243.pub4-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD002243.pub4-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1182\/blood-2006-02-001115","article-title":"Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes","volume":"109","author":"Ehrchen","year":"2007","journal-title":"Blood"},{"issue":"12","key":"10.1002\/14651858.CD002243.pub4-BIB0125|cit125","first-page":"614","article-title":"Steroid therapy in septic shock. Survival studies in a laboratory model","volume":"48","author":"Fabian","year":"1982","journal-title":"American Surgeon"},{"issue":"2","key":"10.1002\/14651858.CD002243.pub4-BIB0126|cit126","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1001\/jamainternmed.2018.5849","article-title":"Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis","volume":"179","author":"Fang","year":"2019","journal-title":"JAMA Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD002243.pub4-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"317-23","DOI":"10.1124\/mol.55.2.317","article-title":"Inhibition of glucocorticoid receptor binding by nitric oxide","volume":"55","author":"Galigniana","year":"1999","journal-title":"Molecular Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD002243.pub4-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"306-11","DOI":"10.1073\/pnas.1210200110","article-title":"Endothelial glucocorticoid receptor is required for protection against sepsis","volume":"110","author":"Goodwin","year":"2013","journal-title":"Proceedings of the National Academy of Science"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0129|cit129","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0131|cit131","article-title":"When to believe a subgroup analysis","volume-title":"User\u2019s Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice","author":"Guyatt","year":"2008"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0132|cit132","unstructured":"Guyatt GH Busse J Methods commentary: risk of bias in randomized trials 1 Evidence Partners http:\/\/distillercer.com\/resources\/methodological resources\/risk-of-biascommentary\/"},{"issue":"9","key":"10.1002\/14651858.CD002243.pub4-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1007\/s00134-003-1831-y","article-title":"Modulation of host defence by hydrocortisone in stress doses during endotoxaemia","volume":"29","author":"Heller","year":"2003","journal-title":"Intensive Care Medicine"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0134|cit134","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.3389\/fimmu.2018.01736","article-title":"Immune effects of corticosteroids in sepsis","volume":"9","author":"Heming","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0135|cit135","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"20","key":"10.1002\/14651858.CD002243.pub4-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.1073\/pnas.83.20.7795","article-title":"Differential effects of transforming growth factor type beta on the growth and function of adrenocortical cells in vitro","volume":"83","author":"Hotta","year":"1986","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1002\/14651858.CD002243.pub4-BIB0137|cit137","first-page":"27","article-title":"Study on glucocorticoid receptors during intestinal ischemia shock and septic shock","volume":"23","author":"Huang","year":"1987","journal-title":"Circulatory Shock"},{"issue":"10","key":"10.1002\/14651858.CD002243.pub4-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002243.pub4-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/endo-128-1-623","article-title":"Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells","volume":"128","author":"Jaattela","year":"1991","journal-title":"Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD002243.pub4-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.chest.2016.07.010","article-title":"Estimating ten-year trends in septic shock incidence and mortality in United States academic medical centers using clinical data","volume":"151","author":"Kadri","year":"2017","journal-title":"Chest"},{"issue":"3","key":"10.1002\/14651858.CD002243.pub4-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"420-9","DOI":"10.1007\/s00134-010-2121-0","article-title":"Low-dose steroids for septic shock and severe sepsis: the use of Bayesian statistics to resolve clinical trial controversies","volume":"37","author":"Kalil","year":"2011","journal-title":"Intensive Care Medicine"},{"issue":"36","key":"10.1002\/14651858.CD002243.pub4-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"14801-6","DOI":"10.1073\/pnas.1313945110","article-title":"Hypothalamo-pituitary and immune-dependent adrenal regulation during systemic inflammation","volume":"110","author":"Kanczkowski","year":"2013","journal-title":"Proceedings of the National Academy of Science"},{"issue":"7","key":"10.1002\/14651858.CD002243.pub4-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/CCM.0000000000000318","article-title":"Early administration of hydrocortisone replacement after the advent of septic shock: impact on survival and immune response","volume":"42","author":"Katsenos","year":"2014","journal-title":"Critical Care Medicine"},{"issue":"15","key":"10.1002\/14651858.CD002243.pub4-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1001\/archinte.167.15.1655","article-title":"Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study","volume":"167","author":"Kellum","year":"2007","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"k3284","DOI":"10.1136\/bmj.k3284","article-title":"Corticosteroid therapy for sepsis: a clinical practice guideline","volume":"362","author":"Lamontagne","year":"2018","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD002243.pub4-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1097\/00003246-199507000-00021","article-title":"Steroid controversy in sepsis and septic shock: a meta-analysis","volume":"23","author":"Lefering","year":"1995","journal-title":"Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD002243.pub4-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/01.CCM.0000259465.92018.6E","article-title":"Adrenal function in sepsis: the retrospective CORTICUS cohort study","volume":"35","author":"Lipiner","year":"2007","journal-title":"Critical Care Medicine"},{"issue":"5","key":"10.1002\/14651858.CD002243.pub4-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2004-12-4790","article-title":"Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn","volume":"106","author":"Lowenberg","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD002243.pub4-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"1937-49","DOI":"10.1097\/CCM.0b013e31817603ba","article-title":"Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine","volume":"36","author":"Marik","year":"2008","journal-title":"Critical Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD002243.pub4-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1378\/chest.114.2.355-a","article-title":"Duration of glucocorticoid treatment and outcome in sepsis: is the right drug used the wrong way?","volume":"114","author":"Meduri","year":"1998","journal-title":"Chest"},{"issue":"12","key":"10.1002\/14651858.CD002243.pub4-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI103772","article-title":"Comparative studies on adrenal cortical function and cortisol metabolism in healthy adults and in patients with shock due to infection","volume":"37","author":"Melby","year":"1958","journal-title":"Journal of Clinical Investigation"},{"issue":"5","key":"10.1002\/14651858.CD002243.pub4-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/PCC.0b013e31828a8125","article-title":"A systematic review and meta-analysis on the effect of steroids in pediatric shock","volume":"14","author":"Menon","year":"2013","journal-title":"Pediatric Critical Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD002243.pub4-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2265.1995.tb01915.x","article-title":"Temperature-induced down-regulation of the glucocorticoid receptor in peripheral blood mononuclear leucocyte in patients with sepsis or septic shock","volume":"43","author":"Molijn","year":"1995","journal-title":"Clinical Endocrinology"},{"issue":"4","key":"10.1002\/14651858.CD002243.pub4-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"R134","DOI":"10.1186\/cc9182","article-title":"Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective","volume":"14","author":"Moran","year":"2010","journal-title":"Critical Care"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0155|cit155","first-page":"30953","article-title":"Can corticosteroids reduce the mortality of patients with severe sepsis? A systematic review and meta-analysis","volume":"S0735-6757","author":"Ni","year":"2018","journal-title":"American Journal of Emergency Medicine"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ams2.322","article-title":"The Japanese clinical practice guidelines for management of sepsis and septic shock 2016 (J-SSCG 2016)","volume":"5","author":"Nishida","year":"2018","journal-title":"Acute Medicine and Surgery"},{"issue":"1","key":"10.1002\/14651858.CD002243.pub4-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrd1283","article-title":"Steroid-hormone rapid actions, membrane receptors, and a conformational ensemble model","volume":"3","author":"Norman","year":"2004","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"1","key":"10.1002\/14651858.CD002243.pub4-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/cc10601","article-title":"Early initiation of low-dose corticosteroid therapy in the management of septic shock: a retrospective observational study","volume":"16","author":"Park","year":"2012","journal-title":"Critical Care"},{"issue":"20","key":"10.1002\/14651858.CD002243.pub4-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM199305203282008","article-title":"Pathogenic mechanisms of septic shock","volume":"328","author":"Parrillo","year":"1993","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD002243.pub4-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jclinepi.2007.11.010","article-title":"Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry","volume":"61","author":"Peters","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD002243.pub4-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"e25905","DOI":"10.1371\/journal.pone.0025905","article-title":"Changes in CRH and ACTH synthesis during experimental and human septic shock","volume":"6","author":"Polito","year":"2011","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0162|cit162","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"13","key":"10.1002\/14651858.CD002243.pub4-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jama.2017.13836","article-title":"Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014","volume":"318","author":"Rhee","year":"2017","journal-title":"JAMA"},{"issue":"16","key":"10.1002\/14651858.CD002243.pub4-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids: new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD002243.pub4-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Medicine"},{"issue":"9","key":"10.1002\/14651858.CD002243.pub4-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/CCM.0000000000003262","article-title":"Corticosteroids in sepsis: an updated systematic review and meta-analysis","volume":"46","author":"Rochwerg","year":"2018","journal-title":"Critical Care Medicine"},{"issue":"8741","key":"10.1002\/14651858.CD002243.pub4-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/0140-6736(91)91641-7","article-title":"Cortisol response to corticotropin and survival in septic shock","volume":"337","author":"Rothwell","year":"1991","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD002243.pub4-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00134-018-5197-6","article-title":"Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis","volume":"44","author":"Ryg\u00e5rd","year":"2018","journal-title":"Intensive Care Medicine"},{"issue":"9398","key":"10.1002\/14651858.CD002243.pub4-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(03)14899-4","article-title":"Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock","volume":"362","author":"Sharshar","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD002243.pub4-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jemermed.2011.08.015","article-title":"Do low-dose corticosteroids improve mortality or shock reversal in patients with septic shock? A systematic review and position statement prepared for the American Academy of Emergency Medicine","volume":"43","author":"Sherwin","year":"2012","journal-title":"Journal of Emergency Medicine"},{"issue":"8","key":"10.1002\/14651858.CD002243.pub4-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0172|cit172","unstructured":"StataCorp. 2015 Stata Statistical Software: Release 14 2015"},{"issue":"657","key":"10.1002\/14651858.CD002243.pub4-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3399\/bjgp17X690401","article-title":"Recognition, diagnosis, and early management of sepsis: NICE guideline","volume":"67","author":"Tavar\u00e9","year":"2017","journal-title":"British Journal of General Practice"},{"issue":"5","key":"10.1002\/14651858.CD002243.pub4-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00024382-200405000-00014","article-title":"Low-dose dexamethasone ameliorates circulatory failure and renal dysfunction in conscious rats with endotoxemia","volume":"21","author":"Tsao","year":"2004","journal-title":"Shock"},{"issue":"6","key":"10.1002\/14651858.CD002243.pub4-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/10739680600777599","article-title":"Glucocorticoids inhibit the cerebral microvascular dysfunction associated with sepsis in obese mice","volume":"13","author":"Vachharajani","year":"2006","journal-title":"Microcirculation"},{"issue":"7","key":"10.1002\/14651858.CD002243.pub4-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets","volume":"17","author":"Poll","year":"2017","journal-title":"Nature Reviews. Immunology"},{"issue":"3","key":"10.1002\/14651858.CD002243.pub4-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1189\/jlb.1107768","article-title":"Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells","volume":"84","author":"Varga","year":"2008","journal-title":"Journal of Leukocyte Biology"},{"issue":"7","key":"10.1002\/14651858.CD002243.pub4-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Medicine"},{"issue":"9868","key":"10.1002\/14651858.CD002243.pub4-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0140-6736(12)61815-7","article-title":"Sepsis definitions: time for change","volume":"381","author":"Vincent","year":"2013","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0180|cit180","unstructured":"WHO Improving prevention, diagnosis and clinical management of sepsis https:\/\/www.who.int\/servicedeliverysafety\/areas\/sepsis\/en\/#.XAAf362Zqkk.mendeley."},{"issue":"1","key":"10.1002\/14651858.CD002243.pub4-BIB0181|cit181","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13054-018-2111-0","article-title":"Corticosteroid use and intensive care unit-acquired weakness: a systematic review and meta-analysis","volume":"22","author":"Yang","year":"2018","journal-title":"Critical Care"},{"issue":"1","key":"10.1002\/14651858.CD002243.pub4-BIB0182|cit182","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002243.pub2","article-title":"Corticosteroids for treating severe sepsis and septic shock","author":"Annane","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1001\/jama.2009.815","article-title":"Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review","volume":"301","author":"Annane","year":"2009","journal-title":"JAMA"},{"issue":"12","key":"10.1002\/14651858.CD002243.pub4-BIB0184|cit184","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002243.pub3","article-title":"Corticosteroids for treating sepsis","author":"Annane","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13054-017-1659-4","article-title":"Corticosteroids in septic shock: a systematic review and network meta-analysis","volume":"21","author":"Gibbison","year":"2017","journal-title":"Critical Care"},{"key":"10.1002\/14651858.CD002243.pub4-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/CCM.0000000000003262","article-title":"Corticosteroids in sepsis: an updated systematic review and meta-analysis","volume":"46","author":"Rochwerg","year":"2018","journal-title":"Critical Care Medicine"}],"updated-by":[{"DOI":"10.1002\/14651858.cd002243.pub5","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD002243.pub4\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T16:54:57Z","timestamp":1694019297000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD002243.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Emergency and Critical Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,12,6]]},"references-count":186,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002243.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,6]]}}}